Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Sadoff

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Vaccine|November 1, 1995
A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivityK L Kotloff, J P Nataro, G A Losonsky, et al.
The Journal of Infectious Diseases|January 11, 1991
Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilinS C Johnson, R C Chung, C D Deal, et al.
The New England Journal of Medicine|June 27, 1996
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study GroupC J Fisher, J M Agosti, S M Opal, et al.
Parasitology|January 1, 1995
Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy studyW R Ballou, J Blood, T Chongsuphajaissidhi, et al.
Infection and Immunity|May 1, 1992
Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin AL F Fries, D M Gordon, I Schneider, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1997
Phase I trial of the SPf66 malaria vaccine in a malaria-experienced population in Southeast AsiaF Nosten, C Luxemburger, D E Kyle, et al.
Lancet (London, England)|November 5, 1994
Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruitsJ L Sanchez, B Vasquez, R E Begue, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1993
Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoitesJ E Egan, S L Hoffman, J D Haynes, et al.
Lancet (London, England)|June 4, 1994
Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparumR A Kuschner, D G Heppner, S L Andersen, et al.
Vaccine|May 1, 1994
Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2D N Taylor, D F Phillip, M Zapor, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Vaccine|November 1, 1995
A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivityK L Kotloff, J P Nataro, G A Losonsky, et al.
The Journal of Infectious Diseases|January 11, 1991
Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilinS C Johnson, R C Chung, C D Deal, et al.
The New England Journal of Medicine|June 27, 1996
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study GroupC J Fisher, J M Agosti, S M Opal, et al.
Parasitology|January 1, 1995
Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy studyW R Ballou, J Blood, T Chongsuphajaissidhi, et al.
Infection and Immunity|May 1, 1992
Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin AL F Fries, D M Gordon, I Schneider, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1997
Phase I trial of the SPf66 malaria vaccine in a malaria-experienced population in Southeast AsiaF Nosten, C Luxemburger, D E Kyle, et al.
Lancet (London, England)|November 5, 1994
Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruitsJ L Sanchez, B Vasquez, R E Begue, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1993
Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoitesJ E Egan, S L Hoffman, J D Haynes, et al.
Lancet (London, England)|June 4, 1994
Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparumR A Kuschner, D G Heppner, S L Andersen, et al.
Vaccine|May 1, 1994
Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2D N Taylor, D F Phillip, M Zapor, et al.
Pageof 12